2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
37
Prostatic Neoplasms
12
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Liver Neoplasms
3
Fibrosis
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Intraductal, Noninfiltrating
3
Uterine Cervical Neoplasms
2
Thyroid Nodule
2
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Lymphoma
2
Lymphedema
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Inflammatory Breast Neoplasms
2
Infertility
2
Hodgkin Disease
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Medullary
2
Carcinoma, Hepatocellular
2
Anatomic Stage III Breast Cancer AJCC v8
2
Interventions
Rocuronium
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
ziprasidone
1
venetoclax
1
saponin QA-21V1
1
perflutren
1
peginesatide
1
hematide
1
finerenone
1
empagliflozin
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Thalidomide
1
Surveys and Questionnaires
1
Stem Cell Transplantation
1
Standard of Care
1
Spironolactone
1
Specimen Handling
1
Simethicone
1
Sevelamer
1
Resistance Training
1
Quillaja Saponins
1
Protein Subunit Vaccines
1
Practice Guidelines as Topic
1
Polymorphism, Genetic
1
Piperacillin, Tazobactam Drug Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency, Chronic
×
High-Energy Shock Waves
×
Clear all
NCT03841149
2026-04-03
VolUS3D
Assistance Publique - Hôpitaux de Paris
Completed
53 enrolled